PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLcp
Lcp
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
83 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bone fracturesD050723EFO_0003931T14.8—2121115
Diabetes mellitusD003920HP_0000819E08-E13———213
Femoral fracturesD005264—S72———123
Chronic kidney failureD007676EFO_0003884N18.9——11—2
Coronary artery diseaseD003324—I25.1———112
AtherosclerosisD050197EFO_0003914I25.1———112
Distal femoral fracturesD000092524—————112
TremorD014202HP_0001337R25.1——11—2
Radius fracturesD011885EFO_0003957————2—2
Wrist fracturesD000092503—————2—2
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Legg-calve-perthes diseaseD007873EFO_0007341M91.2333—1220
OsteonecrosisD010020EFO_0004259M87453—717
Renal insufficiencyD051437HP_0000083N19—34——7
DyslipidemiasD050171HP_0003119——21——2
DeathD003643PATO_0001422——11——2
MelanomaD008545————1——1
Port-wine stainD019339—Q82.5——1——1
Capillary hemangiomaD018324—Q82.5——1——1
NeoplasmsD009369—C80——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NecrosisD009336——23——37
Femur head necrosisD005271——12——24
Liver failureD017093HP_0001399K72.9—2———2
PharmacokineticsD010599———1———1
Autoimmune hepatitisD019693———1———1
HepatitisD006505HP_0012115K75.9—1———1
Hepatitis aD006506EFO_0007305B15—1———1
Shoulder fracturesD012784—S42.9—1———1
Humeral fracturesD006810EFO_0003943S42.3—1———1
Sickle cell anemiaD000755EFO_0000697D57—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteochondritisD010007—M93.91————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PhenylketonuriasD010661—E70.0————22
HypersensitivityD006967HP_0012393T78.40————22
Ventricular tachycardiaD017180—I47.2————11
TachycardiaD013610HP_0001649R00.0————11
Musculoskeletal diseasesD009140——————11
TyrosinemiasD020176—E70.21————11
Rheumatic diseasesD012216—M79.0————11
Spinal fracturesD016103EFO_0003902S12————11
Collagen diseasesD003095——————11
Myocardial infarctionD009203EFO_0000612I21————11
Show 37 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification—
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use